Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation

• Rehan Mujeeb Faridi,

  Affiliation Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Taylor J. Kemp,

  Affiliation Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Poonam Dharmani-Khan,

  Affiliation Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Victor Lewis,

  Affiliation Section of Pediatric Oncology, Blood and Marrow Transplant, Department of Oncology and Pediatrics, Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Gaurav Tripathi,

  Affiliation Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Raja Rajalingam,

  Affiliation Immunogenetics and Transplantation Laboratory, Department of Surgery, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Andrew Daly,

  Affiliation Departments of Medicine and Oncology, Foothills Hospital and Tom Baker Cancer Centre, Calgary, Alberta, Canada

  ⨯
• Noureddine Berka,

  Affiliations Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada, Calgary Laboratory Services, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Jan Storek,

  Affiliations Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada, Departments of Medicine and Oncology, Foothills Hospital and Tom Baker Cancer Centre, Calgary, Alberta, Canada

  ⨯
• Faisal Masood Khan

  * E-mail: fkhan@ucalgary.ca

  Affiliations Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada, Calgary Laboratory Services, University of Calgary, Calgary, Alberta, Canada

  ⨯